State Street’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.24B | Sell |
11,775,227
-13,430
| -0.1% | -$5.98M | 0.2% | 101 |
|
|
2025
Q1 | $5.72B | Sell |
11,788,657
-190,748
| -2% | -$92.5M | 0.24% | 82 |
|
|
2024
Q4 | $4.82B | Buy |
11,979,405
+163,156
| +1% | +$65.7M | 0.19% | 95 |
|
|
2024
Q3 | $5.5B | Buy |
11,816,249
+90,173
| +0.8% | +$41.9M | 0.22% | 79 |
|
|
2024
Q2 | $5.5B | Sell |
11,726,076
-280,407
| -2% | -$131M | 0.24% | 74 |
|
|
2024
Q1 | $5.02B | Sell |
12,006,483
-77,335
| -0.6% | -$32.3M | 0.22% | 84 |
|
|
2023
Q4 | $4.92B | Buy |
12,083,818
+44,272
| +0.4% | +$18M | 0.24% | 77 |
|
|
2023
Q3 | $4.19B | Sell |
12,039,546
-292,047
| -2% | -$102M | 0.23% | 83 |
|
|
2023
Q2 | $4.34B | Buy |
12,331,593
+124,141
| +1% | +$43.7M | 0.23% | 84 |
|
|
2023
Q1 | $3.85B | Sell |
12,207,452
-162,978
| -1% | -$51.3M | 0.22% | 95 |
|
|
2022
Q4 | $3.57B | Buy |
12,370,430
+75,639
| +0.6% | +$21.8M | 0.21% | 98 |
|
|
2022
Q3 | $3.56B | Buy |
12,294,791
+30,742
| +0.3% | +$8.9M | 0.23% | 88 |
|
|
2022
Q2 | $3.46B | Buy |
12,264,049
+211,286
| +2% | +$59.5M | 0.21% | 94 |
|
|
2022
Q1 | $3.15B | Sell |
12,052,763
-304,152
| -2% | -$79.4M | 0.16% | 127 |
|
|
2021
Q4 | $2.71B | Buy |
12,356,915
+33,499
| +0.3% | +$7.36M | 0.13% | 143 |
|
|
2021
Q3 | $2.24B | Buy |
12,323,416
+617,593
| +5% | +$112M | 0.12% | 156 |
|
|
2021
Q2 | $2.36B | Buy |
11,705,823
+530,785
| +5% | +$107M | 0.12% | 155 |
|
|
2021
Q1 | $2.4B | Sell |
11,175,038
-261,026
| -2% | -$56.1M | 0.14% | 137 |
|
|
2020
Q4 | $2.7B | Buy |
11,436,064
+74,118
| +0.7% | +$17.5M | 0.17% | 115 |
|
|
2020
Q3 | $3.09B | Sell |
11,361,946
-306,299
| -3% | -$83.4M | 0.21% | 90 |
|
|
2020
Q2 | $3.39B | Buy |
11,668,245
+219,002
| +2% | +$63.6M | 0.25% | 82 |
|
|
2020
Q1 | $2.72B | Buy |
11,449,243
+54,718
| +0.5% | +$13M | 0.24% | 87 |
|
|
2019
Q4 | $2.49B | Buy |
11,394,525
+80,917
| +0.7% | +$17.7M | 0.17% | 119 |
|
|
2019
Q3 | $1.92B | Sell |
11,313,608
-60,634
| -0.5% | -$10.3M | 0.14% | 158 |
|
|
2019
Q2 | $2.09B | Sell |
11,374,242
-109,804
| -1% | -$20.1M | 0.16% | 133 |
|
|
2019
Q1 | $2.11B | Buy |
11,484,046
+643,769
| +6% | +$118M | 0.16% | 120 |
|
|
2018
Q4 | $1.8B | Sell |
10,840,277
-53,978
| -0.5% | -$8.94M | 0.16% | 128 |
|
|
2018
Q3 | $2.1B | Buy |
10,894,255
+404,711
| +4% | +$78M | 0.16% | 126 |
|
|
2018
Q2 | $1.78B | Buy |
10,489,544
+455,166
| +5% | +$77.4M | 0.15% | 137 |
|
|
2018
Q1 | $1.64B | Sell |
10,034,378
-941,685
| -9% | -$153M | 0.14% | 147 |
|
|
2017
Q4 | $1.64B | Sell |
10,976,063
-242,464
| -2% | -$36.3M | 0.13% | 155 |
|
|
2017
Q3 | $1.71B | Sell |
11,218,527
-140,623
| -1% | -$21.4M | 0.15% | 145 |
|
|
2017
Q2 | $1.46B | Sell |
11,359,150
-654,028
| -5% | -$84.3M | 0.13% | 168 |
|
|
2017
Q1 | $1.31B | Buy |
12,013,178
+239,017
| +2% | +$26.1M | 0.12% | 184 |
|
|
2016
Q4 | $867M | Buy |
11,774,161
+308,574
| +3% | +$22.7M | 0.08% | 259 |
|
|
2016
Q3 | $1,000M | Buy |
11,465,587
+1,639,879
| +17% | +$143M | 0.1% | 223 |
|
|
2016
Q2 | $845M | Buy |
9,825,708
+35,700
| +0.4% | +$3.07M | 0.09% | 244 |
|
|
2016
Q1 | $778M | Sell |
9,790,008
-11,572
| -0.1% | -$920K | 0.08% | 251 |
|
|
2015
Q4 | $1.23B | Buy |
9,801,580
+130,364
| +1% | +$16.4M | 0.13% | 156 |
|
|
2015
Q3 | $1.01B | Buy |
9,671,216
+20,073
| +0.2% | +$2.09M | 0.12% | 187 |
|
|
2015
Q2 | $1.19B | Sell |
9,651,143
-301,592
| -3% | -$37.2M | 0.13% | 171 |
|
|
2015
Q1 | $1.17B | Sell |
9,952,735
-303,130
| -3% | -$35.8M | 0.12% | 183 |
|
|
2014
Q4 | $1.22B | Buy |
10,255,865
+502,104
| +5% | +$59.7M | 0.12% | 186 |
|
|
2014
Q3 | $1.1B | Sell |
9,753,761
-208,163
| -2% | -$23.4M | 0.12% | 186 |
|
|
2014
Q2 | $943M | Sell |
9,961,924
-132,443
| -1% | -$12.5M | 0.1% | 205 |
|
|
2014
Q1 | $714M | Buy |
10,094,367
+457,444
| +5% | +$32.4M | 0.08% | 248 |
|
|
2013
Q4 | $716M | Buy |
9,636,923
+365,348
| +4% | +$27.1M | 0.08% | 247 |
|
|
2013
Q3 | $703M | Buy |
9,271,575
+2,192,814
| +31% | +$166M | 0.09% | 233 |
|
|
2013
Q2 | $565M | Buy |
+7,078,761
| New | +$565M | 0.07% | 279 |
|